US Broker Ratings

Revvity, Inc. (RVTY) Stock Analysis: Navigating Growth with a Strategic Focus in Diagnostics

Revvity, Inc. (RVTY), a prominent player in the healthcare sector specializing in diagnostics and research, presents a compelling investment opportunity with its $13.87 billion market capitalization...

Penumbra, Inc. (PEN) Stock Analysis: Navigating Growth with a 13.88% Potential Upside

As investors scour the healthcare sector for promising opportunities, Penumbra, Inc. (NYSE: PEN) stands out with its innovative medical devices and a market cap of $12.52..

Haleon plc (HLN) Stock Analysis: Exploring a 30% Upside Potential in the Healthcare Sector

Haleon plc (NYSE: HLN), a prominent player in the healthcare sector, is garnering attention from investors thanks to its significant 30.51% potential upside. This UK-based company..

Takeda Pharmaceutical Company L (TAK) Investor Outlook: Analyzing the 23.77% Potential Upside

Takeda Pharmaceutical Company Limited (NYSE: TAK), a prominent player in the healthcare sector, is capturing investor attention with a robust 23.77% potential upside. Headquartered in Chuo,..

Exelixis, Inc. (EXEL) Stock Analysis: Evaluating Growth Potential Amidst a Competitive Biotech Landscape

Exelixis, Inc. (NASDAQ: EXEL) stands as a formidable player in the biotech sector, primarily focusing on developing oncology treatments. With a market capitalization of $13.91 billion,..

West Pharmaceutical Services (WST) Stock Analysis: Robust Growth and a Promising 17% Upside

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector, specializes in providing crucial containment and delivery systems for injectable drugs. With its..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 34.93% Potential Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands out as a compelling player in the healthcare sector, specifically in the drug manufacturing niche focusing on specialty and generic..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 6.20% Dividend Yield Amidst Market Volatility

Pfizer, Inc. (NYSE: PFE), a titan in the healthcare sector, continues to grab investor attention with its robust dividend yield of 6.20%. As a key player..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating Growth Potential with a 12.58% Upside

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the global pharmaceutical arena, offers a compelling narrative for investors with its diversified portfolio and strategic..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Unveiling a 19.59% Potential Upside in the Medical Device Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN) is a stalwart in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $11.51..

Medtronic plc (MDT): Investor Outlook with a 15% Upside Potential

Medtronic plc (NYSE: MDT) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. With its headquarters in Galway, Ireland, Medtronic..

Waters Corporation (WAT) Stock Analysis: Navigating Its 113.40% Revenue Growth Amidst a Promising Analyst Consensus

Waters Corporation (NYSE: WAT) stands as a formidable player in the healthcare sector, specifically in the diagnostics and research industry. Headquartered in Milford, Massachusetts, Waters Corporation..

GSK plc (GSK) Stock Analysis: Exploring a 21.71% Potential Upside for Investors

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, is attracting attention from investors with its promising potential upside of 21.71%. Operating in the drug..

BioNTech SE (BNTX) Stock Analysis: Navigating a 22.28% Potential Upside Amid Biotechnology Volatility

BioNTech SE (BNTX), a German biotechnology heavyweight, has been a notable player in the healthcare sector, primarily recognized for its groundbreaking work in immunotherapies. With a..

Mettler-Toledo International (MTD) Stock Analysis: Evaluating a 12.29% Potential Upside in the Diagnostics Sector

Mettler-Toledo International Inc. (NYSE: MTD), a leading player in the diagnostics and research industry, has long been a name synonymous with precision. Headquartered in Greifensee, Switzerland,..

STERIS plc (STE) Stock Analysis: 24.85% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, STERIS plc (NYSE: STE) presents a compelling case with a potential upside of 24.85%. This Ohio-headquartered company specializes..

Centene Corporation (CNC) Stock Analysis: Evaluating the 8% Upside Potential Amidst Healthcare Growth

Centene Corporation (NYSE: CNC), a significant player in the healthcare plans industry, presents an intriguing opportunity for investors as it navigates the complexities of the U.S...

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A 49% Potential Upside Amidst Biotech Innovations

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands at the forefront of biotechnology innovation, leveraging its expertise in ribonucleic acid interference (RNAi) to develop groundbreaking therapeutics. With a..

Natera, Inc. (NTRA) Stock Analysis: A $47 Billion Market Cap Powerhouse with a Robust Growth Trajectory

Natera, Inc. (NTRA), a leading player in the diagnostics and research sector, has been making waves in the healthcare industry with its innovative molecular testing services...

Molina Healthcare Inc (MOH) Stock Analysis: Navigating the Potential 2.39% Upside Amidst Market Volatility

Molina Healthcare Inc (NYSE: MOH) stands as a prominent player in the healthcare plans industry, with a focus on providing managed healthcare services to low-income families..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds